Cargando…
MiR‐485‐3p serves as a biomarker and therapeutic target of Alzheimer's disease via regulating neuronal cell viability and neuroinflammation by targeting AKT3
BACKGROUND: Numerous microRNAs (miRNAs) have been identified as functional molecules in Alzheimer's disease (AD) pathogenesis. This study aimed to investigate the diagnostic value of microRNA‐485‐3p (miR‐485‐3p) in AD patients, evaluate the effect of miR‐485‐3p on neuronal viability and neuroin...
Autores principales: | Yu, Ling, Li, Haiting, Liu, Wenhu, Zhang, Ligong, Tian, Qun, Li, Hairong, Li, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7963426/ https://www.ncbi.nlm.nih.gov/pubmed/33220166 http://dx.doi.org/10.1002/mgg3.1548 |
Ejemplares similares
-
Targeting MicroRNA-485-3p Blocks Alzheimer’s Disease Progression
por: Koh, Han Seok, et al.
Publicado: (2021) -
Retracted: Yu, L., Li, H., Liu, W., Zhang, L., Tian, Q., Li, H., & Li, M. (2021). miR‐485‐3p serves as a biomarker and therapeutic target of Alzheimer's disease via regulating neuronal cell viability and neuroinflammation by targeting AKT3. Molecular Genetics & Genomic Medicine, 9(1), e1548. https://onlinelibrary.wiley.com/doi/10.1002/mgg3.1548
Publicado: (2021) -
miR-485-5p alleviates Alzheimer’s disease progression by targeting PACS1
por: He, Chuan, et al.
Publicado: (2021) -
Iron-Responsive miR-485-3p Regulates Cellular Iron Homeostasis by Targeting Ferroportin
por: Sangokoya, Carolyn, et al.
Publicado: (2013) -
Long Intergenic Noncoding RNA00265 Enhances Cell Viability and Metastasis via Targeting miR-485-5p/USP22 Axis in Osteosarcoma
por: Chen, Ting, et al.
Publicado: (2022)